Patents by Inventor Peder Lisby Norby

Peder Lisby Norby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Host cell protein knock-out cells for production of therapeutic proteins
    Patent number: 8940504
    Abstract: The present invention relates to methods and means for making Vitamin K-dependent protein compositions which are devoid or substantially devoid of protein contaminants. In particular, methods and means useful for the reduction or elimination of protein contaminants also being Vitamin K-dependent proteins are described.
    Type: Grant
    Filed: March 13, 2012
    Date of Patent: January 27, 2015
    Assignee: Novo Nordisk Healthcare AG
    Inventors: Thomas Dock Steenstrup, Peder Lisby Norby
  • Host Cell Protein Knock-Out Cells for Production of Therapeutic Proteins
    Publication number: 20120171721
    Abstract: The present invention relates to methods and means for making Vitamin K-dependent protein compositions which are devoid or substantially devoid of protein contaminants. In particular, methods and means useful for the reduction or elimination of protein contaminants also being Vitamin K-dependent proteins are described.
    Type: Application
    Filed: March 13, 2012
    Publication date: July 5, 2012
    Applicant: Novo Nordisk Health Care AG
    Inventors: Thomas Dock Steenstrup, Peder Lisby Norby
  • Host cell protein knock-out cells for production of therapeutic proteins
    Patent number: 8158771
    Abstract: The present invention relates to methods and means for making Vitamin K-dependent protein compositions which are devoid or substantially devoid of protein contaminants. In particular, methods and means useful for the reduction or elimination of protein contaminants also being Vitamin K-dependent proteins are described.
    Type: Grant
    Filed: February 4, 2010
    Date of Patent: April 17, 2012
    Assignee: Novo Nordisk Health Care AG
    Inventors: Thomas Dock Steenstrup, Peder Lisby Norby
  • HOST CELL PROTEIN KNOCK-OUT CELLS FOR PRODUCTION OF THERAPEUTIC PROTEINS
    Publication number: 20100137570
    Abstract: The present invention relates to methods and means for making Vitamin K-dependent protein compositions which are devoid or substantially devoid of protein contaminants. In particular, methods and means useful for the reduction or elimination of protein contaminants also being Vitamin K-dependent proteins are described.
    Type: Application
    Filed: February 4, 2010
    Publication date: June 3, 2010
    Applicant: Novo Nordisk Health Care AG
    Inventors: Thomas Dock Steenstrup, Peder Lisby Norby
  • Host cell protein knock-out cells for production of therapeutic proteins
    Patent number: 7696318
    Abstract: The present invention relates to methods and means for making Vitamin K-dependent protein compositions which are devoid or substantially devoid of protein contaminants. In particular, methods and means useful for the reduction or elimination of protein contaminants also being Vitamin K-dependent proteins are described.
    Type: Grant
    Filed: July 13, 2006
    Date of Patent: April 13, 2010
    Assignee: Novo Nordisk Health Care AG
    Inventors: Thomas Dock Steenstrup, Peder Lisby Norby
  • Host Cell Protein Knock-Out Cells for Production of Therapeutic Proteins
    Publication number: 20080299611
    Abstract: The present invention relates to methods and means for making Vitamin K-dependent protein compositions which are devoid or substantially devoid of protein contaminants. In particular, methods and means useful for the reduction or elimination of protein contaminants also being Vitamin K-dependent proteins are described.
    Type: Application
    Filed: July 13, 2006
    Publication date: December 4, 2008
    Applicant: Novo Nordisk Health Care AG
    Inventors: Thomas Dock Steenstrup, Peder Lisby Norby
  • Transducer of MAS signalling
    Publication number: 20030219791
    Abstract: Two receptors of meiosis activating sterols designated SAM1a and SAM1b have been identified.
    Type: Application
    Filed: February 20, 2003
    Publication date: November 27, 2003
    Inventors: Vibeke Westphal Stennicke, Peder Lisby Norby, Christian Grondahl, Philip Wahl